China Universal Asset Management Company’s Silence Therapeutics SLN Stock Holding History
Bought
Maintained
Sold
Other funds holding SLN
China Universal Asset Management Company's SLN Position: Q2 2026 in Review
China Universal Asset Management Company reduced its Silence Therapeutics (SLN) stake by 10% in Q2 2026, selling an estimated $6.05K and leaving 7,475 shares worth $82.1K. The position accounts for ﹤0.01% of the portfolio, ranked #431.
China Universal Asset Management Company first reported a position in SLN in Q4 2024 and has held it in 7 quarters since. The position peaked at $83K in Q4 2025. 4 funds tracked by Wall St. Rank hold SLN as of Q2 2026.
- China Universal Asset Management Company held 7,475 shares of Silence Therapeutics worth $82.1K as of Q2 2026.
- China Universal Asset Management Company sold 860 Silence Therapeutics shares in Q2 2026, an estimated $6.05K.
- Silence Therapeutics made up ﹤0.01% of China Universal Asset Management Company's portfolio in Q2 2026, its #431 holding.
- China Universal Asset Management Company first reported a position in Silence Therapeutics in Q4 2024 and has held it in 7 quarters since.
- China Universal Asset Management Company's Silence Therapeutics position peaked at $83K in Q4 2025.
- 4 funds tracked by Wall St. Rank held Silence Therapeutics as of Q2 2026.
Based on China Universal Asset Management Company's 13F filing for Q2 2026, filed 24 Jul 2026.